A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26671411.
- Also identified by DOI 10.1038/ncomms10186 and PMC identifier 4703869.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The switch between stem/progenitor cell expansion and differentiation is critical for organ homeostasis. The mammalian Hippo pathway effector and oncoprotein YAP expands undifferentiated stem/progenitor cells in various tissues. However, the YAP-associated transcription factors and downstream targets underlying this stemness-promoting activity are poorly understood. Here we show that the SRF-IL6 axis is the critical mediator of YAP-induced stemness in mammary epithelial cells and breast cancer. Specifically, serum response factor (SRF)-mediated binding and recruitment of YAP to mammary stem cell (MaSC) signature-gene promoters induce numerous MaSC signature genes, among which the target interleukin (IL)-6 is critical for YAP-induced stemness. High SRF-YAP/TAZ expression is correlated with IL6-enriched MaSC/basal-like breast cancer (BLBC). Finally, we show that this high SRF expression enables YAP to more efficiently induce IL6 and stemness in BLBC compared with luminal-type breast cancer. Collectively, our results establish the importance of SRF-YAP-IL6 signalling in promoting MaSC-like properties in a BLBC-specific manner.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Breast Neoplasms
- Epithelial Cells
- Interleukin-6
- Mammary Glands, Human
- Neoplastic Stem Cells
- Phosphoproteins
- Serum Response Factor